Literature DB >> 28643049

Clozapine in Reducing Aggression and Violence in Forensic Populations.

Kathleen Patchan1, Gopal Vyas2, Ann L Hackman1, Marie Mackowick3, Charles M Richardson2, Raymond C Love4, Ikwunga Wonodi5, MacKenzie A Sayer5, Matthew Glassman5, Stephanie Feldman5, Deanna L Kelly6.   

Abstract

Popular media often portray people with a mental illness as being aggressive, violent, and incarcerated as a result of their behavior. Despite exaggeration in the media, risks for some aggressive behaviors are in fact higher in individuals with schizophrenia. This is often the case with influence of comorbid substance use disorders. It is essential that mental health professionals are aware of treatments that may help with attenuating and treating behaviors that contribute to violence, aggression and incarceration. This paper reviews violence and incarceration in individuals with schizophrenia as well as recommendations, guidelines and benefits for the use of clozapine in this population. Clozapine remains one of the most underutilized evidence-based medications available in the psychiatric arena in the United States. It is a viable and recommended option in the forensic population and it may be helpful on the path to recovery as well as bring substantial savings to the criminal justice system.

Entities:  

Keywords:  Aggression; Clozapine; Criminal justice; Forensic; Violence

Mesh:

Substances:

Year:  2018        PMID: 28643049      PMCID: PMC5930356          DOI: 10.1007/s11126-017-9521-z

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  72 in total

1.  Patterns of justice involvement among adults with schizophrenia and bipolar disorder: key risk factors.

Authors:  Allison G Robertson; Jeffrey W Swanson; Linda K Frisman; Hsiuju Lin; Marvin S Swartz
Journal:  Psychiatr Serv       Date:  2014-07       Impact factor: 3.084

2.  Clozapine utilization and outcomes by race in a public mental health system: 1994-2000.

Authors:  Deanna L Kelly; Lisa B Dixon; Julie A Kreyenbuhl; Deborah Medoff; Anthony F Lehman; Raymond C Love; Clayton H Brown; Robert R Conley
Journal:  J Clin Psychiatry       Date:  2006-09       Impact factor: 4.384

3.  Clozapine withdrawal rebound psychosis.

Authors:  R L Borison; B I Diamond; D Sinha; R P Gupta; P A Ajiboye
Journal:  Psychopharmacol Bull       Date:  1988

4.  Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.

Authors:  L Citrome; J Volavka; P Czobor; B Sheitman; J P Lindenmayer; J McEvoy; T B Cooper; M Chakos; J A Lieberman
Journal:  Psychiatr Serv       Date:  2001-11       Impact factor: 3.084

5.  Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.

Authors:  Keir Stone-Brown; Mahmood Naji; Alex Francioni; Kyle Myers; Harsh Samarendra; Haseeb Mushtaq-Chaudhry; Stephen Heslop; Samrat Sengupta; Callum C Ross; Fintan Larkin; Mrigendra Das
Journal:  CNS Spectr       Date:  2016-01-04       Impact factor: 3.790

6.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

7.  Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials.

Authors:  K Wahlbeck; M Cheine; A Essali; C Adams
Journal:  Am J Psychiatry       Date:  1999-07       Impact factor: 18.112

8.  Clozapine-induced agranulocytosis in Finland, 1982-2007: long-term monitoring of patients is still warranted.

Authors:  Liisa Lahdelma; Björn Appelberg
Journal:  J Clin Psychiatry       Date:  2012-03-06       Impact factor: 4.384

9.  Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal.

Authors:  T M Shiovitz; T L Welke; P D Tigel; R Anand; R D Hartman; J J Sramek; N M Kurtz; N R Cutler
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

Review 10.  The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Authors:  Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

View more
  4 in total

Review 1.  Comprehensive review on virtual reality for the treatment of violence: implications for youth with schizophrenia.

Authors:  Laura Dellazizzo; Stéphane Potvin; Sami Bahig; Alexandre Dumais
Journal:  NPJ Schizophr       Date:  2019-07-23

2.  Focus on Brain Health to Improve Care, Treatment, and Rehabilitation in Forensic Psychiatry.

Authors:  Peter Andiné; Henrik Bergman
Journal:  Front Psychiatry       Date:  2019-11-26       Impact factor: 4.157

3.  Pharmacological Treatment in Forensic Psychiatry-A Systematic Review.

Authors:  Katarina Howner; Peter Andiné; Göran Engberg; Emin Hoxha Ekström; Eva Lindström; Mikael Nilsson; Susanna Radovic; Monica Hultcrantz
Journal:  Front Psychiatry       Date:  2020-01-16       Impact factor: 4.157

4.  Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study.

Authors:  Cecilia Casetta; Fiona Gaughran; Ebenezer Oloyede; Juliana Onwumere; Megan Pritchard; Sukhi S Shergill; Eromona Whiskey; James Hunter MacCabe
Journal:  BJPsych Open       Date:  2020-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.